Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
- Conditions
- Interventions
- First Posted Date
- 2003-08-07
- Last Posted Date
- 2019-08-06
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 55
- Registration Number
- NCT00066469
- Locations
- 🇺🇸
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
🇺🇸Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸Medical City Dallas Hospital, Dallas, Texas, United States
Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
- First Posted Date
- 2003-08-07
- Last Posted Date
- 2013-10-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 19
- Registration Number
- NCT00066482
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Medical City Dallas Hospital, Dallas, Texas, United States
🇺🇸Children's Memorial Hospital - Chicago, Chicago, Illinois, United States
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
- Conditions
- Interventions
- First Posted Date
- 2003-08-07
- Last Posted Date
- 2015-03-30
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 49
- Registration Number
- NCT00066365
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Miami Children's Hospital, Miami, Florida, United States
🇺🇸Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 38
- Registration Number
- NCT00061893
- Locations
- 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Huntington, West Virginia, United States
Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
- Conditions
- First Posted Date
- 2003-06-05
- Last Posted Date
- 2014-05-05
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 7
- Registration Number
- NCT00008424
- Locations
- 🇨🇦
Hospital for Sick Children, Toronto, Ontario, Canada
🇺🇸Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
- Conditions
- Interventions
- First Posted Date
- 2003-05-22
- Last Posted Date
- 2014-02-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT00006095
- Locations
- 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇦🇺Princess Margaret Hospital for Children, Perth, Western Australia, Australia
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
- First Posted Date
- 2003-05-21
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 83
- Registration Number
- NCT00005977
- Locations
- 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
🇺🇸Texas Oncology P.A., Dallas, Texas, United States
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
- First Posted Date
- 2003-05-19
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 168
- Registration Number
- NCT00003203
- Locations
- 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States
🇨🇦British Columbia Children's Hospital, Vancouver, British Columbia, Canada
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2014-09-22
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 129
- Registration Number
- NCT00059839
- Locations
- 🇺🇸
All Children's Hospital, St. Petersburg, Florida, United States
🇺🇸Nemours Children's Clinic, Jacksonville, Florida, United States
🇵🇷San Jorge Children's Hospital, Santurce, Puerto Rico
Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
- Conditions
- First Posted Date
- 2003-05-02
- Last Posted Date
- 2014-08-07
- Lead Sponsor
- Children's Oncology Group
- Registration Number
- NCT00003933
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸Veterans Affairs Medical Center - Fargo, Fargo, North Dakota, United States
🇺🇸Herbert Irving Comprehensive Cancer Center, New York, New York, United States